MedPath

Multicenter cinical Evaluation Study on the Advantages, indications, and Treatment Paterns of Ganglion Stimulation Therapy-Ganglion Stimulation Therapy for Overactive Bladder

Not Applicable
Conditions
Overactive Bladder
Registration Number
ITMCTR2024000100
Lead Sponsor
Xiyuan Hospital, China Academy of Chinese Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1) Meet the diagnostic criteria for overactive bladder, referring to the Chinese Guidelines for the Diagnosis and Treatment of Urological and Androrological Diseases (2022).
3) Female patients are 18-60 years old (including 18 years old, including 60 years old); male patients are 18-45 years old (including 18 years old, excluding 45 years old).
3) The Chinese and Western drugs used for treating OAB have not been used for nearly one week
4) Sign the informed consent form and volunteer to test.

Exclusion Criteria

Patients with urinary system infections and lower urinary tract obstruction were excluded;
Patients with a neurogenic bladder were excluded;
Exclude patients with urethral dysfunction;
Patients with a residual urine volume of> 50ml were excluded;
Excluding pregnant or lactating patients;
Excluding patients with prostatic hyperplasia and prostatitis;
Patients with contraindications to toterdine tartrate were excluded: urinary retention, gastric stagnation, uncontrolled Angle glaucoma, myasthenia gravis, severe ulcerative colitis, and toxic megacolon;
Excluding patients with proven allergic reactions to toltrine tartrate;
Patients with low renal function, autonomic neurological disease, and hiatal hernia patients were excluded;
Patients with bladder outlet obstruction were excluded due to the risk of urinary retention;
Due to the risk of gastric stagnation, exclude patients with gastrointestinal obstructive diseases, such as stenosis of the pyloric tract;
Excluding patients who have pacemakers, alcohol and metal allergies, or are not suitable for electroacupuncture treatment;
Patients who were judged by the investigator to complete the study were excluded.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath